DK0893121T3 - Flydende oral medicinopløsning - Google Patents

Flydende oral medicinopløsning

Info

Publication number
DK0893121T3
DK0893121T3 DK98202077T DK98202077T DK0893121T3 DK 0893121 T3 DK0893121 T3 DK 0893121T3 DK 98202077 T DK98202077 T DK 98202077T DK 98202077 T DK98202077 T DK 98202077T DK 0893121 T3 DK0893121 T3 DK 0893121T3
Authority
DK
Denmark
Prior art keywords
liquid oral
oral medicine
medicine solution
weight
volume
Prior art date
Application number
DK98202077T
Other languages
English (en)
Inventor
Roger Edward Tully
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0893121T3 publication Critical patent/DK0893121T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK98202077T 1997-06-27 1998-06-23 Flydende oral medicinopløsning DK0893121T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201964 1997-06-27

Publications (1)

Publication Number Publication Date
DK0893121T3 true DK0893121T3 (da) 2002-06-17

Family

ID=8228492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98202077T DK0893121T3 (da) 1997-06-27 1998-06-23 Flydende oral medicinopløsning

Country Status (8)

Country Link
US (1) US6127425A (da)
EP (1) EP0893121B1 (da)
JP (1) JPH1171269A (da)
AT (1) ATE214269T1 (da)
DE (1) DE69804169T2 (da)
DK (1) DK0893121T3 (da)
ES (1) ES2174388T3 (da)
PT (1) PT893121E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US6541367B1 (en) * 2000-01-18 2003-04-01 Applied Materials, Inc. Very low dielectric constant plasma-enhanced CVD films
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
KR101025498B1 (ko) * 2008-05-02 2011-03-31 (주)이엘티사이언스 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
ITUA20162292A1 (it) * 2016-04-05 2017-10-05 Gb Pharma S R L Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (da) *
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DD293263A5 (de) * 1990-03-23 1991-08-29 Adw,Zi Fuer Molekularbiologie,De Mittel zur hemmung des tumorwachstums
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics

Also Published As

Publication number Publication date
DE69804169D1 (de) 2002-04-18
JPH1171269A (ja) 1999-03-16
DE69804169T2 (de) 2002-08-29
ES2174388T3 (es) 2002-11-01
ATE214269T1 (de) 2002-03-15
PT893121E (pt) 2002-06-28
EP0893121B1 (en) 2002-03-13
US6127425A (en) 2000-10-03
EP0893121A1 (en) 1999-01-27

Similar Documents

Publication Publication Date Title
SE8505112D0 (sv) Novel pharmacological compounds
SE8402549L (sv) Substituerade moranolinderivat
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
ATE106860T1 (de) R-enantiomer von n-propargyl-1-aminoindan, dessen herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
FI870219A (fi) Hypoglykemiska tiazolidindioner.
DE3681400D1 (de) Mittel zur mundhygiene.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
DK0893121T3 (da) Flydende oral medicinopløsning
SE8404065D0 (sv) Novel biologically active compounds
HUP0402549A2 (hu) Parenterális paracetamol készítmény
KR880007060A (ko) 제약 조성물
SE8600658D0 (sv) Novel composition of matter
DE69531736D1 (de) Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
FI953566A (fi) Tahdospironia tai sen analogeja sisältäviä koostumuksia
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
EA200100581A1 (ru) Комбинация анальгетических лекарственных средств
KR830004849A (ko) 약학적 제제의 제조방법
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
EA200400954A1 (ru) Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
FI803684L (fi) N-/3-(1'-3"-oxapentametylenamino-etylidenamino)-2,4,6-trijodbenzoyl/-beta-amino-alfa-metylpropionitril och foerfarande foer dess framstaellning
SE8704049D0 (sv) Novel pharmacological compounds